Mitigation of SARS-CoV-2 transmission at a large public university.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
09 06 2022
09 06 2022
Historique:
received:
13
10
2021
accepted:
19
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
In Fall 2020, universities saw extensive transmission of SARS-CoV-2 among their populations, threatening health of the university and surrounding communities, and viability of in-person instruction. Here we report a case study at the University of Illinois at Urbana-Champaign, where a multimodal "SHIELD: Target, Test, and Tell" program, with other non-pharmaceutical interventions, was employed to keep classrooms and laboratories open. The program included epidemiological modeling and surveillance, fast/frequent testing using a novel low-cost and scalable saliva-based RT-qPCR assay for SARS-CoV-2 that bypasses RNA extraction, called covidSHIELD, and digital tools for communication and compliance. In Fall 2020, we performed >1,000,000 covidSHIELD tests, positivity rates remained low, we had zero COVID-19-related hospitalizations or deaths amongst our university community, and mortality in the surrounding Champaign County was reduced more than 4-fold relative to expected. This case study shows that fast/frequent testing and other interventions mitigated transmission of SARS-CoV-2 at a large public university.
Identifiants
pubmed: 35680861
doi: 10.1038/s41467-022-30833-3
pii: 10.1038/s41467-022-30833-3
pmc: PMC9184485
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3207Subventions
Organisme : NIBIB NIH HHS
ID : U54 EB015408
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB027690
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Sci Adv. 2020 Sep 11;6(37):
pubmed: 32917716
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Environ Int. 2020 Aug;141:105794
pubmed: 32416374
PLoS Comput Biol. 2020 Dec 10;16(12):e1008409
pubmed: 33301457
Int Endod J. 2020 Jul;53(7):1017-1019
pubmed: 32344452
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Int J Infect Dis. 2020 May;94:133-138
pubmed: 32247826
JAMA Netw Open. 2020 Jul 1;3(7):e2016818
pubmed: 32735339
Clin Infect Dis. 2021 Aug 16;73(4):e860-e869
pubmed: 33104776
Science. 2021 Aug 27;373(6558):
pubmed: 34446582
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Med (N Y). 2021 Mar 12;2(3):263-280.e6
pubmed: 33521748
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32764-32771
pubmed: 33262277
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
J Biosaf Biosecur. 2021 Jun;3(1):1-3
pubmed: 33521591
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290902
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1416-1418
pubmed: 33001871
Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):
pubmed: 34969678
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Science. 2020 May 8;368(6491):
pubmed: 32234805
Diagnostics (Basel). 2020 May 09;10(5):
pubmed: 32397487
Math Biosci. 2020 Oct;328:108436
pubmed: 32758501
Nat Commun. 2022 Jan 24;13(1):460
pubmed: 35075154
J Infect. 2020 Aug;81(2):e145-e147
pubmed: 32504740
Elife. 2021 Feb 23;10:
pubmed: 33620317
Int J Infect Dis. 2020 Jul;96:288-290
pubmed: 32437933
Front Med (Lausanne). 2020 Aug 04;7:465
pubmed: 32903849
Clin Microbiol Infect. 2022 Apr;28(4):612.e1-612.e7
pubmed: 34826623
Sci Rep. 2021 Mar 15;11(1):5900
pubmed: 33723312
BMJ Open. 2020 Dec 15;10(12):e042578
pubmed: 33323447
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Elife. 2021 Nov 08;10:
pubmed: 34747698
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
PLoS Biol. 2021 Jul 12;19(7):e3001333
pubmed: 34252080
Nat Microbiol. 2022 May;7(5):640-652
pubmed: 35484231
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4
pubmed: 32422408
Oral Dis. 2021 Apr;27 Suppl 3:746-747
pubmed: 32311181
JAMA Intern Med. 2021 Mar 1;181(3):353-360
pubmed: 33449069
mSphere. 2020 Nov 11;5(6):
pubmed: 33177214
Curr Opin Biotechnol. 2004 Jun;15(3):170-4
pubmed: 15193322
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112